Sec. 2301. Funding for COVID–19 vaccine activities at the Centers for Disease Control and Prevention

507 words·~2 min read·/bill/117/hr/1319/enr/section-2301·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

In addition to amounts otherwise available, there is appropriated to the Secretary of Health and Human Services (in this subtitle referred to as the Secretary ) for fiscal year 2021, out of any money in the Treasury not otherwise appropriated, $7,500,000,000, to remain available until expended, to carry out activities to plan, prepare for, promote, distribute, administer, monitor, and track COVID–19 vaccines. The Secretary, acting through the Director of the Centers for Disease Control and Prevention, and in consultation with other agencies, as applicable, shall, in conducting activities referred to in subsection (a)— conduct activities to enhance, expand, and improve nationwide COVID–19 vaccine distribution and administration, including activities related to distribution of ancillary medical products and supplies related to vaccines; and provide technical assistance, guidance, and support to, and award grants or cooperative agreements to, State, local, Tribal, and territorial public health departments for enhancement of COVID–19 vaccine distribution and administration capabilities, including— the distribution and administration of vaccines licensed under section 351 of the Public Health Service Act ( 42 U.S.C. 262 ) or authorized under section 564 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–3 ) and ancillary medical products and supplies related to vaccines; the establishment and expansion, including staffing support, of community vaccination centers , particularly in underserved areas; the deployment of mobile vaccination units, particularly in underserved areas; information technology, standards-based data, and reporting enhancements, including improvements necessary to support standards-based sharing of data related to vaccine distribution and vaccinations and systems that enhance vaccine safety, effectiveness, and uptake, particularly among underserved populations; facilities enhancements; communication with the public regarding when, where, and how to receive COVID–19 vaccines; and transportation of individuals to facilitate vaccinations, including at community vaccination centers and mobile vaccination units, particularly for underserved populations.

In this subsection: The term base formula means the allocation formula that applied to the Public Health Emergency Preparedness cooperative agreement in fiscal year 2020. The term alternative allocation means an allocation to each State, territory, or locality calculated using the percentage derived from the allocation received by such State, territory, or locality of the aggregate amount of fiscal year 2020 Public Health Emergency Preparedness cooperative agreement awards under section 319C–1 of the Public Health Service Act ( 42 U.S.C. 247d–3a ).

Not later than 21 days after the date of enactment of this Act, the Secretary shall, out of amounts described in subsection (a), provide supplemental funding to any State, locality, or territory that received less of the amounts that were appropriated under title III of division M of Public Law 116–260 for vaccination grants to be issued by the Centers for Disease Control and Prevention than such State, locality, or territory would have received had such amounts been allocated using the alternative allocation.

The amount of supplemental funding provided under this subsection shall be equal to the difference between— the amount the State, locality, or territory received, or would receive, under the base formula; and the amount the State, locality, or territory would receive under the alternative allocation.

Connectionstraces to 2

Traces to 2 documents

U.S. Code